Alzheimer’s blood test catches 90% of early dementia cases, study finds
'...One part of the blood test — called plasma phosphorylated tau 217, or p-tau217 for short — is one of several blood biomarkers scientists are evaluating for use in the diagnosis of mild cognitive impairment and early-stage Alzheimer’s disease. ...'
Reference: www.cnn.com
Tags: